Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Microneedles could be a better and easier way to regrow hair.

People with alopecia areata in German-speaking countries spend a lot on their condition, with hair products and treatments being the most costly.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Current treatments for androgenetic alopecia are complex and promising, but more research is needed.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

The conference highlighted new treatments and research in pediatric skin conditions, emphasizing collaboration and innovation.

Hair loss may increase heart disease risk.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Hair follicle-derived melanocyte transplant could effectively treat vitiligo by restoring skin color.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Tofacitinib helped regrow hair in most patients with severe hair loss.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.